Forum Health, LLC, a pioneer in the nationwide network of integrative and functional medicine providers, has announced Sean Whelan as its new chief financial officer. This decision marks a strategic step towards bolstering the company's leadership and fostering growth within the healthcare industry. Whelan's extensive experience, spanning over thirty years with nearly twenty dedicated to healthcare services, positions him as a key figure in steering Forum Health's financial and operational strategies.
Phil Hagerman, CEO of Forum Health, highlighted Whelan's proven track record in healthcare economics and financial leadership as pivotal for the company's next growth phase. Whelan's role will encompass leading financial initiatives aimed at operational efficiency, risk mitigation, and expansion, alongside fostering stakeholder relationships and guiding investments in innovation.
Whelan's career includes significant roles at InfuSystem Holdings, Diplomat Pharmacy, and Smile America Partners, among others. His leadership at Diplomat Pharmacy was instrumental in the company's 2014 Initial Public Offering and its growth to a $4.5 billion business. Whelan expressed his excitement about joining Forum Health, emphasizing the team's commitment to redefining healthcare through integrative and functional medicine.
This appointment is timely for Forum Health as it expands its network of providers focused on personalized healthcare. The company's approach, which integrates functional medicine principles, aims to address the root causes of health issues by considering lifestyle, environmental, and genetic factors. Whelan's expertise is expected to enhance Forum Health's market position and operational efficiency, contributing to improved patient outcomes.
For more information on Forum Health and its services, visit https://www.forumhealth.com.
